Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 73 Carcinoma, Non-Small-Cell Lung 73 Breast Neoplasms 39 Lung Neoplasms 31 Urinary Bladder Neoplasms 28 Nasopharyngeal Carcinoma 28 Ovarian Neoplasms 25 Neoplasm Metastasis 21 Cholangiocarcinoma 18 Triple Negative Breast Neoplasms 16 Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 13 Gallbladder Neoplasms 13 Biliary Tract Neoplasms 13 Uterine Cervical Neoplasms 12 Recurrence 12 Carcinoma, Transitional Cell 12 Nasopharyngeal Neoplasms 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Fallopian Tube Neoplasms 10 Non-Muscle Invasive Bladder Neoplasms 9 Lymphoma 7 Carcinoma 7 Bile Duct Neoplasms 7 Lymphoma, Non-Hodgkin 6 Adenocarcinoma 6 Carcinoma, Hepatocellular 5 Adenocarcinoma of Lung 5 Neoplasms by Site 4 Urothelial Cancer 3

Interventions

Cisplatin 3 durvalumab 1 Sodium Chloride 1 Gemcitabine 1 Carboplatin 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Locally Advanced Cervical Cancer × Gemcitabine × Clear all

NCT06156514 2025-05-28

MICHELE

National Institute of Cancerología

Phase 3 Recruiting

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡